Telocyte

I confess that I’ve yet to find time to continue through each of several age-related diseases. In partial recompense, let me offer the following, which is adapted from the quarterly newsletter that I put out for Telocyte. While it focuses on Alzheimer’s disease, the import is generic, applying to all age-related diseases. How Alzheimer’s works […]

Many of you have written to me, expressing surprise about the lack of public reaction (such as media interest) regarding the potential for telomerase therapy to treat age-related diseases. Some of you wonder why people (and particularly the media) “don’t get it”. I’ve had the same thought for a bit more than two decades now, […]

A physician friend asked if a patient’s APOE status (which alleles they carry, for example APOE4, APOE3, or APOE2) would effect how well they should respond to telomerase therapy. Ideally, it may not make much difference, except that the genes you carry (including the APOE genes and the alleles for each type of APOE gene, […]

Several of you have asked why I don’t update this blog more often. My priority is to take effective interventions for age-related diseases to FDA phase 1 human trials, rather than blogging about the process. Each week, Outlook reminds me to update the blog, but there are many tasks that need doing if we are […]

Hardly a day goes by, and never an entire week, without my seeing yet another article, often a cover article, that suggests we will soon cure Alzheimer’s disease. If articles were anything to go by, then the increasing tempo of those articles, to say nothing of the increases in both research and funding, would suggest […]

We waste stunning amounts of money and effort on comprehensively ineffective trials. As a recent article points out, in the past 15 years, there have been 123 Alzheimer drug failures and, while four medicines have been approved, none of them affect the progress of the disease. Symptomatic therapy at best, we have no medications – […]

Perspective often shrinks personal problems. Late Sunday night, I received a cry for help from a woman whose mother has Alzheimer’s disease: she asked me to meet her family and offer professional advice. Their concern was not only her medications, but the ability of her physician, the stress on the family, and the patient’s own […]

The other day, a friend of mine, Liz Parrish, the CEO and founder of BioViva, made quite a splash when she injected herself with a viral vector containing genes for both telomerase and FST. Those in favor of what Liz did applaud her for her courage and her ability to move quickly and effectively in […]

Our new biotechnology company, Telocyte, is moving along, as can be seen in our website. Our mission is simple: we intend to cure Alzheimer’s disease. We have no intention of “ameliorating”, “slowing”, or “improving the care for” Alzheimer’s disease. Instead, our goal is to prevent and cure it entirely. No one should ever have to […]